The quality of the Compounded Sterile Preparation you administer to patients is of the utmost importance. It’s critical that your hospital pharmacy adheres to all state boards of pharmacy and federal regulations, and that you do everything you can to ensure drug quality. A Compounding Management System helps with both.
The ConsortiEX family is currently ramping up for the 2019 ASHP Midyear Clinical Meeting, but we want to take a moment to thank all of our customers for their continued partnership on our journey to improve patient outcomes, and in securing the pharmaceutical supply chain. We remain committed to providing health care[...]
We would like to thank all attendees of the ASHP Summer Meetings who stopped by to see us. Having the opportunity to discuss our compliance solutions, in-person, is one that we do not take for granted.
ConsortiEX will be shipping up to Boston for this year’s ASHP Summer Meeting. We encourage you to stop at Booth 201 for an in-person look at how you can use our intuitive DQSA Compliance solutions to enhance patient safety, ensure quality control and simplify your compliance needs.
ConsortiEX is proud to announce T3 verification, the newest feature to be added to our DSCSA Compliance as a Service (CaaS) module. The T3 Verification process gives pharmacies maximum visibility to all T3 transactions, both electronic and paper, received by their pharmacy.
The FDA released a finalized questions and answers guidance on data integrity compliance. The FDA guidance adheres to requirements under current good manufacturing practice ( cGMP) for drugs and biologics.
The FDA has issued a guidance to 503B facilities regarding Current Good Manufacturing Practice (gCMB)
The FDA recently issued a draft guidance regarding verification* systems in accordance with the Drug Supply Chain Security Act (DSCSA).
Just last week, ConsortiEX proudly announced our new InsightRX Passive Audit Monitoring module.
Today, cost and quality issues surrounding compounded sterile preparations (CSP’s) have nearly every major health system investigating what it takes to re-insource production. Most are looking at a hub and spoke approach, where their central-fill Batch Compounding can support the CSP production needs of all the[...]